Business Context and Reporting Period
Company: NeOnc Technologies Holdings, Inc. (NTHI)
Filing Type: Form 8-K (Current Report)
Date of Report: November 7, 2025
Reporting Period: Event date November 7, 2025; Report signed November 10, 2025
Business Context: The Company is an emerging growth company incorporated in Delaware, focused on clinical development. This filing serves as a Regulation FD disclosure regarding an upcoming investor conference call.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The primary event is the announcement of a scheduled investor conference call to present data updates.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will host an investor conference call and webcast on Wednesday, November 12, 2025, at 9:00 a.m. Eastern Time.
- Subject Matter: The call will present data updates from the ongoing Phase 1/2a NEO100-1 clinical trial and the compassionate use program.
- Disclosure Status: The information in this Item 7.01 and the accompanying press release (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Verify the date and time of the investor conference call (November 12, 2025, 9:00 a.m. ET).
- Review the attached Press Release (Exhibit 99.1) for specific details on the NEO100-1 clinical trial data.
- Confirm the status of the compassionate use program updates to be presented.
- Note that this filing does not contain audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.